WOC2014 TOKYOランチョンセミナー

World Ophthalmology Congress® of the International Council of Ophthalmology
2014年 4月5日(土) 12:15 13:15
Date : Saturday, April 5, 2014 12:15-13:15
Seminar 40
第9会場(東京国際フォーラム ガラス棟6階 G602)
Venue : Room No. 9 / G602 / Tokyo International Forum
Recent managements of retinitis pigmentosa
三宅 養三
先生(愛知医科大学 理事長)
Yozo Miyake, M.D., Ph.D., Chairman of the Board of Directors, Aichi Medical University
Epidemiologic researches of RP patients with mid to late stages are necessary to develop appropriate clinical
endpoints for coming new treatments. Although visual acuity is the most common clinical endpoint, it takes
long time to show the prevention of loss of vision in the clinical trial through new therapies. To develop the new
therapies for RP, clinician scientists who are familiar with not only basic and clinical researches but also applied
research will play important roles.
In this seminar, three clinician scientists will present the managements of recent RP treatments: clinical
endpoints for RP study, gene therapy, and iPS cell therapy.
Program 1
“Evaluation of visual function in retinitis pigmentosa”
山本 修一
先生(千葉大学大学院医学研究院眼科学 教授)
Shuichi Yamamoto, M.D., Ph.D., Vice Director of Chiba University Hospital
Professor and Chairman, Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine
Program 2
“Phase I clinical trial of neuroprotective gene therapy for
patients with retinitis pigmentosa”
池田 康博
先生(九州大学大学院医学研究院 眼科学 講師)
Yasuhiro Ikeda, M.D., Ph.D., Assistant professor, Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University
Program 3
“Application of iPS cells for retinal diseases”
高橋 政代
先生(理化学研究所 発生・再生科学総合研究センター 網膜再生医療研究開発プロジェクト プロジェクトリーダー)
Masayo Takahashi, M.D., Ph.D., Project Leader, Laboratory for Retinal Regeneration, Center for Developmental Biology, RIKEN, Japan
The talks in this seminar will be given in Japanese.
共催:WOC2014 TOKYO/株式会社アールテック・ウエノ